FFR/QFR registry for heart artery assessment
Part of Heart & circulation clinical trials.
This study collects information from people who have had a standard heart test called FFR to measure blood flow in their arteries. It aims to better understand how this test helps guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had a clinically needed FFR procedure (either planned or done during another procedure).
- You cannot take part if you decide not to join the registry and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific heart blood-flow measurement taken during a coronary procedure to see how well it predicts future outcomes. If you had a successful pressure measurement called FFR with a tracing, your results may be analyzed to understand risk and prognosis.
This study follows people who have narrowed heart arteries and have a pressure test (FFR) to guide treatment. It may help doctors understand the course of disease when using FFR and choosing a minimally invasive approach.
This trial tests a new way to measure resistance in the heart's small and large arteries during a standard angiogram. It may help doctors better understand and treat blockages or microvascular disease.
This study is following people with chronic coronary syndrome to see how a special CT-based blood flow test (CT-FFR) helps predict their heart health. If you have already had this test, you may be eligible to join and help doctors learn more about managing your condition.
This trial uses a special pressure wire called RFR to help doctors decide whether a stent is needed for a moderate heart artery blockage. It aims to make sure only the blockages that really need treatment get stented, which may reduce unnecessary procedures.
This study tests whether a CT scan combined with blood-flow measurements can better predict which heart artery blockages are serious. It may help avoid unnecessary invasive tests.
Hear when a new Coronary Artery Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.